Fluorine F 18 Fluorodopa
Sponsors
Mayo Clinic, University of Virginia
Conditions
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Diffuse AstrocytomaAdult EpendymomaAdult Giant Cell GlioblastomaAdult Glioblastoma
Early Phase 1
Fluorine F 18 Fluorodopa-Labeled PET Scan in Planning Surgery and Radiation Therapy in Treating Patients With Newly Diagnosed High- or Low-Grade Malignant Glioma
CompletedNCT01165632
Start: 2010-07-26End: 2019-07-26Updated: 2025-09-02
18F-DOPA-PET in Planning Surgery in Patients With Gliomas
CompletedNCT02020720
Start: 2014-01-22End: 2024-01-10Updated: 2025-01-23
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
NCT04315584
Start: 2020-03-15End: 2024-06-20Target: 5Updated: 2020-03-24
Phase 2
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
CompletedNCT01991977
Start: 2013-12-31End: 2024-07-15Updated: 2025-10-20
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
CompletedNCT03242824
Start: 2017-09-29End: 2021-06-16Updated: 2023-03-14